Fortrea (FTRE) Stock Price & Analysis

FTRE$19.79-0.41 -2.03%
Biotechnology
Compare
Market cap$1.87BEnterprise value$2.80BRevenue (TTM)$2.67BMarket position—

AI Analysis

Snapshot

Fortrea Holdings (FTRE) trades at $19.79, with a trailing P/E of n/a. This snapshot uses the price and valuation already on the page. It is a description of the reported figures, not a recommendation.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

…
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

…
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

…
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Fortrea Holdings Inc. (FTRE) last printed $19.79. Equity value is $1.87B. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

202020212022202320242025
$2.58B$3.06B$2.84B$2.84B$2.7B$2.72B

About

Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.

Fortrea (FTRE) Stock Price & Analysis

FTRE price $19.79 -0.41 -2.03%

Ticker
FTRE
Price
$19.79
Change
-0.41 -2.03%
Market cap
$1.87B
Forward P/E
23.31
Dividend yield
0.00%
Beta
1.86
Sector
Healthcare
Industry
Biotechnology

Insights · Forecast · Financials · Learn

Stocklytics home · Screener